Vivek Roy, M.D., is a hematologist-oncologist with more than 25 years of both clinical and research experience specializing in hematologic malignancies and stem cell transplantation. His predominant professional activity is as a clinician providing care to patients with blood disorders and patients undergoing stem cell transplantation.
As a researcher, Dr. Roy has studied hematopoietic stem cells in the laboratory, characterizing stem cells obtained from disparate sources. His research activities are focused on novel approaches to improve the outcomes of hematopoietic stem cell transplantation, stem cell mobilization and clinical trials to develop novel therapies for multiple myeloma, amyloidosis, and hematologic malignancies.
- Bone marrow transplantation
- Multiple myeloma
- Hematologic malignancies
Significance to patient care
Through his research in collaboration with Mayo Clinic research teams, Dr. Roy is helping improve the care of transplant patients and developing new treatment options for patients with multiple myeloma, amyloidosis and other blood cancers.
- Member, Editorial Board, ISRN Stem Cells
- Member, Mayo Clinic Comprehensive Cancer Center and its Hematologic Malignancies Program